Hey readers! Here's a number that reframes how we think about diagnosis: in population screening studies, most celiac cases turned up in people whose regular doctors never caught them. This week we've got the review behind that finding, two new national screening programs about to launch, a Canadian tax break you can actually claim, and a mobile lab option for at-home testing. Let's get into the concrete places to go.
🔍 The screening gap, in plain terms
Celiac Disease Screening: Why Diagnosis Misses Cases is the piece to read first: an international scoping review published online October 22, 2026 in Clinical Gastroenterology and Hepatology found that across population-based studies, roughly 60-75% of screening-identified cases had not been picked up by routine clinical practice.
– PashutFree
The nuance matters, and the authors are careful about it. That 60-75% is not an estimate of anyone's personal risk, and it does not mean most people with celiac worldwide are undiagnosed.
The 60-75% figure is not an estimate of everyone's personal risk, and universal screening is not yet standard policy.
Why does usual care miss them? The review notes that many screened individuals had no classic digestive symptoms and no known close relatives with celiac. If your detection system leans on symptoms or family history, those patterns slip through. The practical takeaways for families are worth repeating: raise concerns with a qualified clinician, share relevant family and medical history so targeted testing can be considered, and do not drop gluten before diagnostic testing unless advised, because doing so can muddy the results.
🌍 Two countries are about to test kids before symptoms show
If the review names the problem, these next two stories are what a policy response looks like.
Al via lo screening per celiachia e diabete in specifiche età pediatriche reports that, following a pilot involving more than 5,500 children across four Italian regions, the Conferenza Stato-Regioni gave a positive opinion on November 6, 2026 to the national pediatric screening program for type 1 diabetes and celiac disease, making Italy's Law 130/2023 operational.
– Il Pediatra
Screening diabete tipo 1 e celiachia: si parte in primavera adds the timeline from Health Minister Orazio Schillaci, speaking on November 4, 2026: the screening starts in spring 2027 for children who have turned 5 but not yet 7, with the invitation arriving alongside scheduled vaccinations and participation voluntary, requiring informed consent from both parents.
– AIS
The design is a small capillary blood draw looking for disease-associated markers, with positive results referred to regional clinical centers for confirmation. The logic ties the two conditions together: celiac disease and type 1 diabetes are both autoimmune and share HLA-DQ2 and HLA-DQ8 haplotypes, and celiac prevalence runs higher in children with type 1 diabetes. This is exactly the kind of program that could reach the symptom-free, no-family-history cases the scoping review flagged.
Poland is moving too. Ministerstwo Zdrowia potwierdza. Od stycznia nowe badania na NFZ confirms that from January 1, 2027, Poland's NFZ will fund new celiac diagnostic tests, adding anti-tTG antibody testing in IgA and IgG classes to guaranteed outpatient specialist care.
– Rynek Zdrowia
The stat that stings: the article reports celiac diagnosis in Poland takes an average of 7 years (9 years in adults, 3.1 years in children). Reimbursing the frontline antibody tests is a direct attempt to shorten that lag.
🧪 Tools and tests worth knowing about
Several developments speak to catching and confirming cases more reliably.
Generalisability of an adult-trained AI model to paediatric coeliac disease diagnosis is a multicentre validation study in which an AI model trained only on adult duodenal biopsy images held up in children, reaching a paediatric AUC of 98.8% with no misclassifications among its high-confidence predictions.
– ScienceDirect
One clinical reminder from that study: including both the bulb (D1) and descending (D2/3) sites improved performance, reinforcing multi-site biopsy sampling. Diagnostic help like this matters most where pathology expertise is thin.
Getlabs Expands Mobile Collection to Genova Diagnostics' Food Sensitivity and GI Panels now covers in-home collection for a Celiac panel and GI/Celiac SNP genetic testing across a network spanning 35 states.
– PR Newswire
Patients today expect healthcare to meet them where they are.
For someone already managing GI symptoms, skipping the trip to a draw site is a small but real lowering of the barrier to getting tested. Just remember the review's caution: confirmatory testing and clinical follow-up still belong with your care team.
And on the research horizon:
Celiac follow-up: a new blood-protein research project describes a three-year Coeliac UK project, led by Ludvig Sollid at the University of Oslo, studying protein signals tied to low-level intestinal inflammation in people who stay unwell on a gluten-free diet. It is explicitly a research plan, not an available test and not permission to eat gluten.
Blood may reveal signs of gut-related disease that stool samples miss reports that serum short-chain fatty acid profiles outperformed fecal ones at distinguishing celiac, colorectal cancer, and obesity from healthy controls (95% vs 59% accuracy), though larger cohorts are needed before it's a clinical test.
👧 Who to watch, and the diabetes link
The higher-risk-group question the review raised shows up vividly in children with type 1 diabetes.
Incidence and Associated Risk Factors of Coeliac Disease in Children Newly Diagnosed With Type 1 Diabetes is a 5-year nationwide prospective study from Kuwait of 1,934 children: 3.4% developed biopsy-confirmed celiac, with 40% diagnosed within the first year after their diabetes diagnosis.
– PMC
The practical message is timing. Celiac showed up most often early after type 1 diabetes onset, and younger children carried higher risk, which argues for front-loading screening attention right after a diabetes diagnosis rather than spreading it thinly over years.
That said, the workup has to actually happen. Fewer than half of newly diagnosed children with type 1 diabetes get autoantibody testing found that only 48.8% of 68,439 children received at least one recommended islet autoantibody test around diagnosis.
– Managed Healthcare Executive
The untested children represent a meaningful gap in the diagnostic workup.
It's a different disease, but the same theme: a recommended test that routinely doesn't get ordered is how cases stay hidden.
📚 Also on our radar
Harmonizing scientific terms and concepts in early celiac disease: a review in Gut led by Karolinska Institutet and Mayo Clinic, with input from 22 scientists across seven countries, standardizing the vocabulary of early celiac disease. As first author Jonas F. Ludvigsson puts it, "Celiac disease is a quickly evolving field."
Genetic Analysis Links Celiac Disease to Ankylosing Spondylitis Risk: a Mendelian randomization study in BMC Rheumatology reports genetic evidence that celiac disease may causally raise ankylosing spondylitis risk (OR 1.435), though the data skews European and needs prospective validation.
MUSC Children's Health expands digestive disease care in South Carolina: more pediatric GI access across coastal South Carolina, with clinicians urging early attention to warning signs like stomach pain, bloating, and persistent diarrhea.
💵 A win for Canadian wallets
Celiac Canada applauds support for Canadians with celiac disease in Budget 2026 reports that, starting with the 2026 taxation year, people with celiac disease can claim an optional flat $1,000 under the Medical Expense Tax Credit for incremental gluten-free food costs, no more receipt-tracking and price-difference math, though a certified medical validation letter is still required.
– Celiac Canada / Newswire
Living with celiac disease isn't a choice, yet people with the condition must pay significantly more for the food they need to stay healthy.
Budget 2026 Offers Relief to People Living with Celiac Disease adds context: the article estimates about 400,000 Canadians live with celiac and up to 80% may be undiagnosed, with gluten-free bread running upwards of $9 a loaf.
– VOCM
🍽️ One practical note for daily life
Whether you're newly diagnosed or a seasoned pro, eating out and traveling remains one of the trickier parts of the gluten-free life, and a survey this issue confirmed that young people with celiac eat fewer lunches in cafeterias (18% vs 38%) partly because safe options are hard to find. For scouting restaurants with reviews from other people who get it, we genuinely like Find Me Gluten Free (https://www.findmeglutenfree.com/) and its app. We're not sponsored by them; it's just a resource that earns its spot on a lot of phones.
That's the issue. The through-line is simple: the tests and programs that catch celiac often aren't the ones that happen by default. If something here resonates with your own situation, bring it to your clinician, and keep eating well.